Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
House of the Great Gardener is a premier cannabis breeding and genetics company dedicated to the development of stabilized, high-quality medicinal cannabis strains. With over two decades of experience in the industry, the company focuses on creating unique terpene and cannabinoid profiles to address specific patient needs, including pain management and neurological disorders. Their portfolio includes numerous award-winning varieties such as Barbara Bud and GG#4, which are utilized by licensed producers and medical cultivators globally. By combining traditional breeding techniques with modern genetic analysis, House of the Great Gardener ensures the consistency and efficacy of botanical starting materials for the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on House of the Great Gardener.